Boston Scientific reports significant growth in endoscopy business – grows 54 percent
In Q2, medtech firm Boston Scientific sold significantly more endoscopy products, which is the core business area of Danish company Ambu. The US giant is upgrading its guidance for the whole year.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Medtech giant Boston Scientific has had the wind in its sails during the second quarter of 2021.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Össur key market sales normalize during second quarter
For subscribers
Ambu gets recommendation from FDA, analyst doubts effect
For subscribers
Analyst: Pentax partnership might lead Ambu to new market
For subscribers
.jpg&w=384&q=75)
